Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Therapy for Pediatric Beta-Thalassemia Major
NCT04292314Phase 3Completed
- Sponsor
- Beni Suef University
- Start
- Nov 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of hydroxyurea, omega-3-acid triglycerides, black seed oil and Revamil in beta thalassemia, sponsored by Beni Suef University. Started Nov 2019; status: completed.
02
Drugs
hydroxyureaomega-3-acid triglyceridesblack seed oilRevamil
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT04292314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04292314.